LAB Act

Hozzl · 2022-10-28T01:45:57Z

Explore the details of Senate Bill 3049 LAB Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

10/28/2022, 1:45 AM

Congressional Summary of S 3049

Laboratory Access for Beneficiaries Act or the LAB Act

This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3049

Bill S 3049 is currently in the status of Bill Introduced since December 12, 2019. Bill S 3049 was introduced during Congress 116 and was introduced to the Senate on December 12, 2019. Bill S 3049's most recent activity was Read twice and referred to the Committee on Finance. as of December 12, 2019

Bipartisan Support of Bill S 3049

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3049

Primary Policy Focus

Health

Potential Impact Areas

- Congressional oversight

- Drug safety, medical device, and laboratory regulation

- Government information and archives

- Government studies and investigations

- Health care costs and insurance

- Health information and medical records

- Inflation and prices

- Medical tests and diagnostic methods

- Medicare

Alternate Title(s) of Bill S 3049

LAB Act

Laboratory Access for Beneficiaries Act

A bill to amend title XVIII of the Social Security Act to provide for certain amendments relating to reporting requirements with respect to clinical diagnostic laboratory tests, and for other purposes.